- Joined
- Mar 31, 2020
- Messages
- 9,153
- Points
- 113
Corbevax | At Rs 250 per dose, Biological E's Corbevax may be India’s cheapest COVID-19 vaccine
www.timesnownews.com
Throwing light on its pricing strategy, TOI quoted Dr Maria Elena Bottazi, associate dean, National School of Tropical Medicine (NSTM) who said that the Corbevax has been modelled after the hepatitis B vaccine and uses traditional technology.
This is cheap to produce at only about $1.5 (Rs 110 approximately) per dose, she added.
While SII’s is priced at Rs 300 a dose for state governments and Rs 600 a dose for private hospitals, Bharat Biotech’s Covaxin is selling for Rs 400 and Rs 1,200.
Russian vaccine Sputnik V has been priced at Rs 995 per jab.
Centre pays advance for 30 crore Biological-E vaccine doses
BCM-Biological E Vaccine will be robust: Dr Peter Hotez
Meanwhile, the Union Health Ministry has finalised arrangements with Biological-E to reserve 30 crore COVID-19 vaccine doses by making it an advance payment of Rs 1500 crore.
These vaccine doses will be manufactured and stockpiled by Biological-E from August to December this year, a ministry statement said on Thursday.
Corbevax is an RBD protein sub-unit vaccine and is likely to be available in the next few months.
The new COVID-19 vaccine has been backed by the Union government from the preclinical stage to phase-3 studies.
“The Department of Biotechnology has not only provided financial assistance in terms of grant-in-aid of over Rs 100 crore but has also partnered with Biological-E to conduct all animal challenge and assay studies through its Research Institute Translational Health Science Technology Institute (THSTI), Faridabad,” the Health Ministry release stated.
www.timesnownews.com
This is cheap to produce at only about $1.5 (Rs 110 approximately) per dose, she added.
Two doses of Corbevax may even be priced below Rs 400
The report further states that two doses of Corbevax may even be priced below Rs 400.While SII’s is priced at Rs 300 a dose for state governments and Rs 600 a dose for private hospitals, Bharat Biotech’s Covaxin is selling for Rs 400 and Rs 1,200.
Russian vaccine Sputnik V has been priced at Rs 995 per jab.
Centre pays advance for 30 crore Biological-E vaccine doses
BCM-Biological E Vaccine will be robust: Dr Peter Hotez
Meanwhile, the Union Health Ministry has finalised arrangements with Biological-E to reserve 30 crore COVID-19 vaccine doses by making it an advance payment of Rs 1500 crore.
These vaccine doses will be manufactured and stockpiled by Biological-E from August to December this year, a ministry statement said on Thursday.
Corbevax has shown promising results in phase 1 and 2 trials
The COVID-19 vaccine of Biological-E is currently undergoing phase-3 clinical trial after showing promising results in phase 1 and 2 trials.Corbevax is an RBD protein sub-unit vaccine and is likely to be available in the next few months.
The new COVID-19 vaccine has been backed by the Union government from the preclinical stage to phase-3 studies.
“The Department of Biotechnology has not only provided financial assistance in terms of grant-in-aid of over Rs 100 crore but has also partnered with Biological-E to conduct all animal challenge and assay studies through its Research Institute Translational Health Science Technology Institute (THSTI), Faridabad,” the Health Ministry release stated.
